Introduction {#Sec1}
============

Prokaryotic cells contain a number of small DNA-binding proteins with the primary function of compacting and organizing genomic DNA (Grove and Saavedra [@CR13]). The integration host factor (IHF) belongs to the group of histone-like proteins (Bewley et al. [@CR5]; Drlica and Rouviere-Yaniv [@CR7]). It has been characterized by X-ray structural analysis as a small heterodimeric protein consisting of two related α and β subunits, each with a molecular weight of about 10 kDA (Fig. [1](#Fig1){ref-type="fig"}) (Rice et al. [@CR27]; Pettijohn [@CR24]). IHF binds DNA with considerable sequence specificity and affects many cellular processes. Facilitation of λ phage integration and involvement in the transcriptional regulation of gene expression and DNA replication binding to oriC are functions of IHF in *Escherichia coli* (Moitoso de Vargas et al. [@CR22]; Ussery et al. [@CR32]; Filutowicz and Appelt [@CR10]). A highly conserved consensus sequence within the binding sites (H1, H2, H′) of the phage attachment area is recognized by IHF (Rice et al. [@CR27]; Friedman [@CR12]). The co-crystal structure of IHF with a 35 bp DNA containing the H′-binding site of the λ phage reveals that the two subunits are intertwined to form a compact largely α-helical body from which two long β-ribbon arms extend (Fig. [1](#Fig1){ref-type="fig"}). These arms recognize dsDNA in the minor groove, whereas the positively charged protein core interacts non-specifically mainly with the poly-anionic DNA backbone, inducing a bend of at least 160°. Proline residues located close to the tip of both arms intercalate between the base pairs accounting for the kinks (Rice et al. [@CR27]; Rice [@CR26]). Sequence specificity of IHF recognition is derived from indirect readout by shape recognition of the minor groove next to a negligible amount of hydrogen bonding (Rice [@CR26]; Swinger and Rice [@CR31]). Nevertheless, the contribution to sequence specificity is much higher for the IHF α-arm extending more deeply into the minor groove than the β-arm (Rice et al. [@CR27]). Interestingly, as derived from the co-crystal structure the Pro65 of the α-arm adopts an exo-conformation whereas the intercalating Pro64 of the β-subunit is crystallized as the endo-conformer.Fig. 1Co-crystal strucutre of the IHF protein domain bound to the 35 bp dsDNA H′-binding site and expanded view of the α-subunit with the proline residue intercalating between nucleobases thymine 37 and 38 (Rice et al. [@CR27])

Intercalation of proline (**1**) is of importance in the IHF-induced process of DNA bending. Therefore, other amino acids with higher sterical demand or conformational preorganization were investigated in order to examine the influence on dsDNA binding and bending. An aromatic side chain derived from phenylalanine (Phe, **2**) was explored next to the cyclic amino acid 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Thi, **3**) combining the properties of an aromatic and a cyclic amino acid side chain. Furthermore, the proline conformations found in the IHF/DNA co-crystal structure can be stabilized by fluorine (Barth et al. [@CR2]; Hodges and Raines [@CR15]; Renner et al. [@CR25]; Shoulders et al. [@CR29]; Kim et al. [@CR18]), azide (Sonntag et al. [@CR30]; Erdmann et al. [@CR8]) or hydroxyl ring substituents (Lesarri et al. [@CR19]) at C3 or C4. Especially, the highly polarized C--F bond is suited to provide the endo-conformation in case of (4S)-fluoroproline ((4S)-FPro, **4**) and the exo-conformation in case of (4R)-fluoroproline ((4R)-FPro, **5**) (Fig. [2](#Fig2){ref-type="fig"}) (Horng and Raines [@CR16]; Naduthambi and Zondlo [@CR23]). The possibility to generate conformationally constrained proline rings was used to investigate the influence of various proline derivatives incorporated in the β-sheet loop structure of the IHF α-arm. The (4S)-FPro and (4R)-FPro derivatives were compared to peptides containing 3,4-dehydroproline (Dh-Pro, **6**) (Benedetti et al. [@CR3]; Fisher et al. [@CR11]), and the α-methylproline (αMe-Pro, **7**) (Welsh et al. [@CR33]; Hinds et al. [@CR14]) with respect to binding and intercalation in dsDNA (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Proline and derivatives that were incorporated into the β-sheet loop of peptide IHF-mimics representing the intercalating proline in the α-arm of IHF

The system used for investigation of DNA interaction of the respective proline derivatives was based on an IHF mimicking peptide **8** (Fig. [3](#Fig3){ref-type="fig"}) reported earlier (Liebler and Diederichsen [@CR20]). A three generation lysine dendrimer was used to imitate the positively charged body of IHF providing a comparable amount of positive charges under physiological conditions. The dendrimer is connected with the minor groove recognition motive by a glycine heptapeptide. As mimic for the IHF α-arm a cyclopeptide was chosen in order to retain the β-sheet hairpin conformation. A sequence of ten amino acids around the intercalating proline (-GRNP65KTGEDI-) was used in homology to the IHF α-arm. Elongation by the two amino acids, diaminopropionic acid (Dap) and [d]{.smallcaps}-Pro allow for side chain attachment and provide the template for β-turn formation. The resulting cyclopeptide is likely to retain the required β-sheet loop conformation for minor groove recognition. Binding studies performed by gel electrophoresis reveal affinity of the IHF mimic **8** to dsDNA containing the λ phage H′-binding site and also a tendency for bending dsDNA.Fig. 3Representation of peptide **8** designed for mimicking the native DNA-binding IHF domain

Based on IHF mimicking peptide **8,** the influence of the aromatic side chains at the proline intercalation site and of proline derivatives with defined conformation were investigated. Intercalation of the IHF α-arm mimics in dsDNA were examined preparing derivatives of construct **8** varying the intercalating proline to Phe (**2**), Thi (**3**), (4S)-FPro (**4**), (4R)-FPro (**5**), Dh-Pro (**6**) and αMe-Pro (**7**). For preparation of the IHF mimics a modular approach was used connecting the dendrimer/linker construct to the respective cyclopeptide. Binding of dsDNA was investigated by gel electrophoresis and fluorescence resonance energy transfer (FRET).

Materials and methods {#Sec2}
=====================

General remarks {#Sec3}
---------------

All reagents were of analytical grade and used without further purification. Solvents were of the highest grade available; dry solvents were stored over molecular sieves (4 Å). Glass equipment used for reactions under inert atmosphere was flame dried before use. ESI-MS data were obtained with a *Finnigan* (type LGC or TSQ 7000) spectrometer, high resolution spectra were obtained with a *Bruker* (FT ICR MS, Apex-Q IV 7T) mass spectrometer. For automated SPPS a peptide synthesizer 433 A from Applied Biosystems was used. The *FastMoc* 0.10 mmol or *FastMoc* 0.25 mmol (amount of resin) Fmoc standard protocol in a 8 or 41 mL reaction vessel were used. HPLC analyses were performed on a Pharmacia Biotech Äkta Basic (pump type P-900, variable wavelength detector) or a *JASCO* HPLC (pump type PU-2080 plus, variable wavelength detector). UV absorption was detected at 215 nm with a linear gradient of A (0.1% TFA in H~2~O) to B (0.1% TFA in MeCN) for the *JASCO* HPLC or A (0.1% TFA in H~2~O) to B′ (0.1% TFA in MeCN/H~2~O 8:2) or B″ (0.1% TFA in MeCN/H~2~O 9:1) for Pharmacia Äkta Basic. Peptides were analyzed using a YMC J'sphere column ODS-H80, RP-C18, 250 × 4.6 mm, 4 μm, 80 Å or a *JASCO* Reprosil, RP-C4, 250 × 4 mm, 5 μm, 80 Å with a flow rate of 1 mL min^−1^. Purification was performed with a *JASCO* Reprosil, RP-C4, 250 × 10 mm, 5 μm, 80 Å with a flow rate of 3 mL min^−1^ or *YMC* J' sphere column ODS-H80, RP-C18, 250 × 20 mm, 4 μm, 80 Å with a flow rate of 10 mL min^−1^. The fractions containing the desired product were collected and lyophilized. Fluorescence measurements were taken on a *JASCO* FP-6200 instrument. The 55 bp FRET DNA containing the H′-binding site was commercially available.

H-Dap(Alloc)[d]{.smallcaps}-ProGlyArg(Pbf)Asn(Trt)XPLys(Boc)Thr(tBu)GlyGlu(tBu)Asp(tBu)Ile-OH (10a-f) {#Sec4}
-----------------------------------------------------------------------------------------------------

Peptides **10a**--**f** were synthesized by automated SPPS on isoleucine preloaded 2-chlorotrityl resin according to standard Fmoc chemistry protocols (**10a, c, d***FastMoc* 0.10 mmol, **10b, e, f***FastMoc* 0.25 mmol). Double coupling was performed for the respective α-methylproline derivative. The peptide was cleaved from the resin with 30% HFIP in DCM (5 mL) for 45 min at r.t. The crude product **10a**--**f** was precipitated in cold ether (5 mL) and purified by reverse phase HPLC to give the linear peptide as a white solid. **10a** Yield: 63.6 mg, 29%. HPLC (50 → 90% B″ in 30 min) *t*~R~: 26.8 min. ESI-MS *m/z*: 1,106 (100%) \[M + 2Na\]^2+^, 1,095 (80) \[M + H + Na\]^2+^. HR-MS (ESI): \[C~109~H~158~N~18~O~26~S\] \[M + 2H\]^2+^ calcd. 1,083.5652 found 1,083.5650. **10b** Yield: 442 mg, 81%. HPLC (50 → 100% B′ in 30 min) *t*~R~: 29.9 min. ESI-MS *m/z*: 2,200 (100%) \[M + Na\]^+^, 2,179 (75) \[M + H\]^+^. HR-MS (ESI): \[C~110~H~158~N~18~O~26~S\] \[M + 2H\]^2+^ calcd. 1,089.5652 found 1,089.5655. **10c** Yield: 75.5 mg, 36%. HPLC (60 → 100% B in 30 min) *t*~R~: 18.4 min. ESI-MS *m/z*: 2,133 (100%) \[M + H\]^+^, 1,079 (55) \[M + H + Na\]^2+^. HR-MS (ESI): \[C~105~H~155~N~18~O~26~SF\] \[M + 2H\]^2+^ calcd. 1,067.55268 found 1,067.55273. **10d** Yield: 55.5 mg, 26%. HPLC (60 → 100% B in 30 min) *t*~R~: 17.8 min. ESI-MS *m/z*: 2,133 (100%) \[M + H\]^+^, 2,131 (78) \[M-H\]^−^, 1,079 (100) \[M + H + Na\]^2+^. HR-MS (ESI): \[C~105~H~155~N~18~O~26~SF\] \[M + 2H\]^2+^ calcd. 1,067.55268 found 1,067.55248. **10e** Yield: 391 mg, 74%. HPLC (60 → 100% B′ in 30 min) *t*~R~: 23.5 min. ESI-MS *m/z*: 2,114 (92%) \[M + H\]^+^, 2,112 (100) \[M-H\]^−^. HR-MS (ESI): \[C~105~H~154~N~18~O~26~S\] \[M + 2H\]^2+^ calcd. 1,057.54957 found 1,057.54894. **10f** Yield: 111 mg, 26%. HPLC (60 → 100% B in 30 min) *t*~R~: 15.9 min. ESI-MS *m/z*: 2,152 (80%) \[M + Na\]^+^, 2,130 (100) \[M + H\]^+^, 1,066 (100) \[M + 2H\]^2+^. HR-MS (ESI): \[C~106~H~158~N~18~O~26~S\] \[M + 2H\]^2+^ calcd. 1,065.56522 found 1,065.56507.

*Cyclo*\[Dap(Alloc)[d]{.smallcaps}-ProGlyArg(Pbf)Asn(Trt)XPLys(Boc)Thr(tBu)GlyGlu(tBu)Asp(tBu)Ile\] (11a--f) {#Sec5}
------------------------------------------------------------------------------------------------------------

Under inert gas atmosphere the respective linear precursor **10a--f** was dissolved in DCM/DMF (9:1) until a 10^−3^--10^−4^[m]{.smallcaps} solution was reached. DIC (10 equiv), HOAt (1 equiv, 0.5 mol/L in DMF) and NMM (3 equiv) were added and the reaction mixture was stirred at r.t. for 2 days. After removal of solvents the residue was dissolved in MeOH (1 mL for 10 mg peptide) and purified by reverse phase HPLC. **11a** Yield: 60%. HPLC (80 → 100% B″ in 30 min) *t*~R~: 21.9 min. ESI-MS *m/z*: 1,097 (100%) \[M + 2Na\]^2+^, 1,086 (10) \[M + H + Na\]^2+^. HR-MS (ESI): \[C~109~H~155~N~18~O~25~SNa\] \[M + H + Na\]^2+^ calcd. 1,085.5509 found 1,085.5503, \[C~109~H~156~N~18~O~25~S\] \[M + 2H\]^2+^ calcd. 1,074.5599 found 1,074.5609. **11b** Yield: 63%. HPLC (70 → 100% B in 30 min) *t*~R~: 21.5 min. ESI-MS *m/z*: 2,160 (100%) \[M + H\]^+^. HR-MS (ESI): \[C~110~H~156~N~18~O~25~S\] \[M + 2H\]^2+^ calcd. 1,080.5599 found 1,080.5600. **11c** Yield: 58%. HPLC (60 → 100% B in 30 min) *t*~R~: 21.9 min. ESI-MS *m/z*: 2,139 (100%), \[M + Na\]^+^. HR-MS (ESI): \[C~105~H~152~FN~18~O~25~SNa\] \[M + H + Na\]^2+^ calcd. 1,069.53837 found 1,069.53814, \[C~105~H~153~FN~18~O~25~S\] \[M + 2H\]^2+^ calcd. 1,058.5470 found 1,058.54653. **11d** Yield: 86%. HPLC (60 → 100% B in 30 min) *t*~R~: 23.5 min. ESI-MS *m/z*: 2,139 (100%) \[M + Na\]^+^, 1,081 (70) \[M + 2Na\]^2+^. HR-MS (ESI): \[C~105~H~152~FN~18~O~25~SNa\] \[M + H + Na\]^2+^ calcd. 1,069.53837 found 1,069.53926, \[C~105~H~153~FN~18~O~25~S\] \[M + 2H\]^2+^ calcd. 1,058.5470 found 1,058.54753. **11e** Yield: 64%. HPLC (60 → 100% B in 30 min) *t*~R~: 28.5 min. ESI-MS *m/z*: 2,119 (100%) \[M + Na\]^+^, 2,093 (20) \[M-H\]^−^. HR-MS (ESI): \[C~105~H~152~N~18~O~25~S\] \[M + 2H\]^2+^ calcd. 1,048.54429 found 1,048.54429. **11f** Yield: 66%. HPLC (60 → 100% B in 30 min) *t*~R~: 15.9 min. ESI-MS *m/z*: 2,135 (100%) \[M + Na\]^+^. HR-MS (ESI): \[C~106~H~156~N~18~O~25~S\] \[M + 2H\]^2+^ calcd. 1,056.55994 found 1,056.56065.

*Cyclo*\[Dap[d]{.smallcaps}-ProGlyArg(Pbf)Asn(Trt)XPLys(Boc)Thr(tBu)GlyGlu(tBu)Asp(tBu)Ile\] (12a--f) {#Sec6}
-----------------------------------------------------------------------------------------------------

The respective cyclic peptide **11a--f** was dissolved in dry DMF (1 mL for 10 mg peptide) under inert gas atmosphere. Me~2~NH·BH~3~ (40 equiv) and Pd(PPh~3~)~4~ (0.1 equiv) were added and the reaction mixture was stirred at r.t. for 4 h. After removing the solvent, the crude product **12** was purified via reverse phase HPLC. **12a** Yield: 71%. HPLC (80 → 100% B′ in 30 min) *t*~R~: 29.1 min. ESI-MS *m/z*: 2,064 (100%) \[M + H\]^+^. HR-MS (ESI): \[C~105~H~152~N~18~O~23~S\] \[M + 2H\]^2+^ calcd. 1,032.5494 found 1,032.5494. **12b** Yield: 38%. HPLC (50 → 100% B in 30 min) *t*~R~: 20.4 min. ESI-MS *m/z*: 2,075 (20%) \[M + H\]^+^. HR-MS (ESI): \[C~106~H~151~N~18~O~23~SNa\] \[M + H + Na\]^2+^ calcd. 1,049.5404 found 1,049.5402, \[C~106~H~152~N~18~O~23~S\] \[M + 2H\]^2+^ calcd. 1,038.5494 found 1,038.5497. **12c** Yield: 35%. HPLC (60 → 100% B′ in 30 min) *t*~R~: 25.7 min. ESI-MS *m/z*: 2,032 (100%) \[M + H\]^+^, 2,030 (76) \[M-H\]^−^, 1,028 (100) \[M + H + Na\]^2+^. HR-MS (ESI): \[C~101~H~149~FN~18~O~23~S\] \[M + 2H\]^2+^ calcd. 1,016.53648 found 1,016.53634. **12d** Yield: 28%. HPLC (60 → 100% B′ in 30 min) *t*~R~: 23.1 min. ESI-MS *m/z*: 2,031 (100%) \[M + H\]^+^, 2,029 (92) \[M-H\]^−^, 1,028 (100) \[M + H + Na\]^2+^, 1,017 (12) \[M + 2H\]^2+^. HR-MS (ESI): \[C~101~H~149~FN~18~O~23~S\] \[M + 2H\]^2+^ calcd. 1,016.53648 found 1,016.53634. **12e** Yield: 66%. HPLC (60 → 100% B in 30 min) *t*~R~: 20.1 min. ESI-MS *m/z*: 2,012 (100%) \[M + H\]^+^, 2,011 (52) \[M-H\]^−^, 1,018 (100) \[M + H + Na\]^2+^. HR-MS (ESI): \[C~101~H~148~N~18~O~23~S\] \[M + 2H\]^2+^ calcd. 1,006.53372 found 1,006.53319. **12f** Yield: 48%. HPLC (60 → 100% B in 30 min) *t*~R~: 17.3 min. ESI-MS *m/z*: 2,050 (19%) \[M + Na\]^+^, 2,028 (100) \[M + H\]^+^, 1,015 (78) \[M + 2H\]^2+^, 960 (31) \[M + 4H\]^4+^. HR-MS (ESI): \[C~102~H~152~N~18~O~23~S\] \[M + 2H\]^2+^ calcd. 1,014.54937 found 1,014.54850.

\[Boc-Lys(Me~2~)\]~4~Lys~2~LysGly~7~-*cyclo*\[Dap[d]{.smallcaps}-ProGlyArg(Pbf)Asn(Trt)XPLys(Boc)Thr(tBu)Gly Glu(tBu)Asp(tBu)\] (13a--f) {#Sec7}
----------------------------------------------------------------------------------------------------------------------------------------

Under inert gas atmosphere a solution of dendrimer **9** (2.5 equiv), DIC (8 equiv), HOAt (3 equiv) and NMM (3 equiv) in dry DMF (1 mL for 50 mg dendrimer) was added to the cyclopeptides **12a,b** dissolved in dry DMF (1 mL for 20 mg cyclopeptide). The reaction mixtures were stirred at r.t. for 7 h. Reverse phase HPLC afforded **13a, b** as a white solid. **13a** Yield: 49%. HPLC (50 → 90% B′ in 30 min) *t*~R~: 20.6 min. ESI-MS *m/z*: 1,936 (100%) \[M + 4H\]^4+^, 1,292 (16) \[M + 3H\]^3+^. HR-MS (ESI): \[C~189~H~307~N~39~O~45~S\] \[M + 4H\]^4+^ calcd. 968.8158 found 968.8156. **13b** Yield: 66%. HPLC (50 → 100% B′ in 30 min) *t*~R~: 17.6 min. ESI-MS *m/z*: 1,296 (25%) \[M + 3H\]^3+^, 972 (100) \[M + 4H\]^4+^. HR-MS (ESI): \[C~190~H~306~N~39~O~45~S\] \[M + 3H\]^3+^ calcd. 1,295.4186 found 1,295.4186, \[C~190~H~307~N~39~O~45~S\] \[M + 4H\]^4+^ calcd. 971.8158 found 971.8155. Under inert gas atmosphere dendrimer **9** (2 equiv) and the respective cyclopeptide **12c**--**f** (1 equiv) were dissolved in dry DMF (500 μL). Then DIC (8 equiv), HOAt (7.9 equiv, 0.5 mol/L in DMF) and NMM (10 equiv) were added. The reaction mixture was stirred at r.t. for 2 days, then the solvent was removed in vacuum. The residue was purified by reverse phase HPLC. **13c** Yield: 58%. HPLC (20 → 80% B in 30 min) *t*~R~: 23.5 min. ESI-MS *m/z*: 3,840 (100%) \[M + H\]^+^, 961 (69) \[M + 4H\]^4+^. HR-MS (ESI): \[C~185~H~304~FN~39~O~45~S\] \[M + 4H\]^4+^ calcd. 960.80953 found 960.80896, \[C~185~H~305~FN~39~O~45~S\] \[M + 5H\]^5+^ calcd. 768.84908 found 768.84901. **13d** Yield: 63%. HPLC (20 → 80% B in 30 min) *t*~R~: 21.3 min. ESI-MS *m/z*: 3,840 (100%) \[M + H\]^+^, 961 (57) \[M + 4H\]^4+^. HR-MS (ESI) \[C~185~H~302~FN~39~O~45~S\] \[M + 2H\]^2+^ calcd. 960.80953 found 960.80938. **13e** Yield: 33%. HPLC (20 → 80% B in 30 min) *t*~R~: 20.7 min, ESI-MS *m/z*: 3,842 (16%) \[M + Na\]^+^, 3,820 (100) \[M + H\]^+^. HR-MS (ESI): \[C~185~H~303~N~39~O~45~S\] \[M + 4H\]^4+^ calcd. 955.80798 found 955.80810. **13f** Yield: 63%. HPLC (20 → 80% B in 30 min) *t*~R~: 22.3 min. ESI-MS *m/z*: 3,858 (85%) \[M + Na\]^+^, 3,836 (30) \[M + H\]^+^. HR-MS (ESI): \[C~186~H~307~N~39~O~45~S\] \[M + 4H\]^4+^ calcd. 959.81580 found 959.81562.

\[Lys(Me~2~)\]~4~Lys~2~LysGly~7~-*cyclo*\[Dap[d]{.smallcaps}-ProGlyArgAsnXPLysThrGlyGluAspIle\] (14a--f) {#Sec8}
--------------------------------------------------------------------------------------------------------

The respective coupling product **13a--f** was dissolved in 95% aq. TFA and stirred for 90 min at r.t. After removing the TFA and purification via reverse phase HPLC the IHF mimic **14a--f** was obtained. **14a** Yield: 76%. HPLC (5 → 40% B′ in 30 min) *t*~R~: 17.5 min. ESI-MS *m/z*: 1,356 (100%) \[M + 2H\]^2+^, 904 (75) \[M + 3H\]^3+^. HR-MS (ESI): \[C~120~H~215~N~39~O~32~\] \[M + 6H\]^6+^ calcd. 452.4394 found 452.4394. **14b** Yield: 76%. HPLC (5 → 40% B′ in 30 min) *t*~R~: 14.7 min. ESI-MS *m/z*: 908 (100%) \[M + 3H\]^3+^. HR-MS (ESI): \[C~121~H~213~N~39~O~32~\] \[M + 4H\]^4+^ calcd. 681.1554 found 681.1554, \[C~121~H~214~N~39~O~32~\] \[M + 5H\]^5+^ calcd. 545.1258 found 545.1259. **14c** Yield: 86%. HPLC (3 → 40% B in 30 min) *t*~R~: 6.9 min. ESI-MS *m/z*: 2,678 (100%) \[M + H\]^+^, 670 (15) \[M + 4H\]^4+^, 536 (54) \[M + 5H\]^5+^, 447 (35) \[M + 6H\]^6+^. HR-MS (ESI): \[C~116~H~211~FN~39~O~32~\] \[M + 5H\]^5+^ calcd. 536.32078 found 536.32080. **14d** Yield: 84%. HPLC (3 → 40% B in 30 min) *t*~R~: 7.2 min. ESI-MS *m/z*: 2,678 (100%) \[M + H\]^+^, 893 (4) \[M + 3H\]^3+^, 670 (32) \[M + 4H\]^4+^, 536 (51) \[M + 5H\]^5+^, 447 (15) \[M + 6H\]^6+^. HR-MS (ESI): \[C~116~H~210~FN~39~O~32~\] \[M + 4H\]^4+^ calcd. 670.14915 found 670.14919. **14e** Yield: 76%. HPLC (3 → 40% B in 30 min) *t*~R~: 17.7 min. ESI-MS *m/z*: 2,657 (100%) \[M + H\]^+^, 665 (15) \[M + 4H\]^4+^, 532 \[M + 5H\]^5+^. HR-MS (ESI): \[C~116~H~209~N~39~O~32~\] \[M + 4H\]^4+^ calcd. 665.14760 found 665.14750, \[C~116~H~210~N~39~O~32~\] \[M + 5H\]^5+^ calcd. 532.31953 found 532.31938. **14f** Yield: 84%. HPLC (3 → 40% B in 30 min) *t*~R~: 5.7 min. ESI-MS *m/z*: 2674 (100%) \[M + H\]^+^, 669 (24) \[M + 4H\]^4+^, 536 (53) \[M + 5H\]^5+^, 446 (36) \[M + 6H\]^6+^. HR-MS (ESI): \[C~117~H~213~N~39~O~32~\] \[M + 4H\]^4+^ calcd. 669.15542 found 669.15569, \[C~117~H~214~N~39~O~32~\] \[M + 5H\]^5+^ calcd. 535.52579 found 535.52595.

PCR {#Sec9}
---

PCR was carried out in a MWG Biotech thermal cycler Primus 96 Plus. 1 μL template DNA, 1 μL primer-up, 1 μL primer down, 1 μL dNTPs, 5 μL Taq buffer and 40 μL H~2~O were placed in small reaction tubes (0.2--0.5 mL) and were covered with a layer of 30 μL chillout-wax. The following programs were accomplished: 3 min 95°C, 2 min 85°C Taq polymerase (1 μL) was added, \[1 min 95°C, 1 min 50°C, 1 min 72°C (30 repeats)\]; 10 min 72°C. The PCR products were analyzed via 1% agarose gel electrophoresis. The generated DNA fragments were combined and 1/10 part by volume 7 [m]{.smallcaps} NH~4~Ac and three parts by volume 96% EtOH were added to precipitate the DNA. After vortexing the probe was centrifuged (2 × 3 min) and the supernatant was discarded. The resulting pellet was dried in a heating block at 42°C and resuspended in water. The DNA was cut out of a 1% agarose gel and isolated with a Prep EaseTM Gel Extraction Kit. The DNA concentration was determined with a photometer and the purity was analyzed via 1% agarose gel electrophoresis. Sequence primers: H′-middle up: 5′-CATGC ATCTG TCGCA GTAGG ACTCA CGACT GATCT AGTCG ACGTA G\\\\GTTT CTCGT TCAGC TTTTT TATAC-3′; H′-middle down: 5′-TCACA GTATC GTGAT GACAG AG-3′; H′-edge up: 5′-CATTA TAAAA AAGCA TTGCT TATC-3′; H′-edge down: 5′-TCTGC AAGAC TCTAT GAGAA GC-3′; Sequence 200 bp DNA H′-middle: 5′-CATGC ATCTG TCGCA GTAGG ACTCA CGACT GATCT AGTCG ACGTA GGTTT CTCGT TCAGC TTTTT TATAC TAAGT TGGCA TTATA AAAAA GCATT GCTTA TCAAT TTGTT GCAAC GAACA GGTCA CTATC AGTCA AAATA AAATC ATTAT TTGAT TTCAA TTTTG TCCCA CTCCC TGCCT CTGTC ATCAC GATAC TGTGA-3′; Sequence 200 bp DNA H′-edge: 5′-CATTA TAAAA AAGCA TTGCT TATCA ATTTG TTGCA ACGAA CAGGT CACTA TCAGT CAAAA TAAAA TCATT ATTTG ATTTC AATTT TGTCC CACTC CCTGC CTCTG TCATC ACGAT ACTGT GATGC CATGG TGTCC GACTT ATGCC CGAGA AGATG TTGAG CAAAC TTATC GCTTA TCTGC TTCTC ATAGA GTCTT GCAGA-3′.

Results and discussion {#Sec10}
======================

Synthesis of IHF mimics with different intercalating amino acids {#Sec11}
----------------------------------------------------------------

The preparation of IHF mimicking peptides followed the general approach described earlier for the convergent synthesis of mimic **8** (Liebler and Diederichsen [@CR20]). The glycine heptamer linker with lysine dendrimer was built by automated SPPS on a glycine preloaded 2-chlorotrityl resin. The first two generations of the lysine dendrimer were added using Fmoc-Lys(Fmoc)-OH; the third lysine layer was attached applying Boc-Lys(Me)~2~-OH, which was obtained in two steps following literature procedures (Benoiton [@CR4]; Hughes et al. [@CR17]). After cleavage from the solid support the lysine dendrimer/linker building block was obtained as Boc-protected carboxylic acid **9** (Scheme [1](#Sch1){ref-type="fig"}). The cyclopeptides **12a**--**f** were also assembled by SPPS as linear dodecamer on an isoleucine preloaded 2-chlorotrityl resin. The proline derivatives **3**--**7** were Fmoc-protected as described in literature (Ruan et al. [@CR28]; Albericio [@CR1]) and incorporated in the respective peptide sequences. Cleavage of the peptides from solid support was accomplished under mild conditions using 30% 1,1,1,3,3,3-hexafluoro-isopropanol (HFIP) in dichloromethane (DCM) (Bollhagen et al. [@CR6]).Scheme 1Synthesis of IHF analogs with varying amino acid residue (XP) that mimics the intercalating proline

The resulting side chain protected oligomers **10a--f** were readily cyclized under dilution conditions in DCM/DMF adding *N,N′*-diisopropylcarbodiimide (DIC) as coupling reagent together with 1-hydroxy-7-azabenzotriazole (HOAt) and *N*-methyl-morpholine (NMM) as base to yield cyclopeptides **11a--f**.

Orthogonal removal of the Alloc protecting group (Fernandez-Forner et al. [@CR9]) on the diaminopropionic acid (Dap) with Pd(PPh~3~)~4~ and Me~2~NH·BH~3~ as scavenger provided cyclopeptides **12a--f** ready for coupling with the dendrimer/linker construct **9** using DIC, HOAt and NMM activation in DMF. Finally, the resulting peptides **13a--f** were deprotected at the lysine dendrimer and at the side chains of the cyclopeptides to provide the IHF mimicking constructs **14a--f**.

DNA binding and bending of IHF analog 8 {#Sec12}
---------------------------------------

Based on the specificity of IHF mimic **8** for the 34 bp H′-binding site (Swinger and Rice [@CR31]) bending studies were performed using gel electrophoresis (Wu and Crothers [@CR34]). 200 bp DNA double strands were used containing the H′-binding site either in a central (H′-middle) or in a terminal position (H′-edge). Specific binding and bending of one of the mimics leads to differently shaped DNA-peptide complexes. Binding to the H′-edge site results in a more linear shaped complex compared to H′-middle binding; the linear complex moves faster through an agarose gel (Wu and Crothers [@CR34]). However, both complexes should be significantly retarded in comparison to dsDNA.

For preparation of 200 bp DNA the H′-edge was amplified from the 502 bp attP site (λ phage) together with 166 additional base pairs by PCR. In case of the H′-middle fragment, 83 extra base pairs on both sites (5′ and 3′) were required. Unfortunately, the H2-binding site is located only 37 bp next to the H′-binding site. Using the same amplifying strategy as before the H2-binding site would also be present offering a second binding site. Therefore, elongated 5′-primers containing a 46 bp random sequence attachment together with the 37 bp between the H′ and H2-binding sites were used for amplification.

Gel electrophoresis of the 200 bp DNA with H′-edge or H′-middle positioning of the recognition sequence, respectively (lanes 2, 3 and 10, 11, Fig. [4](#Fig4){ref-type="fig"}), was performed adding 60 equivalents of IHF-mimic **8** (lanes 4 and 5) in Tris--HCl buffer (10 m[m]{.smallcaps} Tris--HCl, 10 m[m]{.smallcaps} EDTA, 100 m[m]{.smallcaps} NaCl, 1 m[m]{.smallcaps} dithiothreitol, pH 7.5) with an incubation time of 2 h at r.t. followed by 1 h at 4°C. Both bands were significantly shifted whereas the higher bent complex was retarded (lane 4) with respect to the more linear adduct (lane 5). Bending of dsDNA induced by IHF mimic **8** is indicated; nevertheless, the difference in retardation is significantly lower compared to respective IHF/DNA complexes. The endonuclease *Tsp*509 is a restriction enzyme with AATT-site specificity to cleave in the H′-binding site. Nevertheless, the IHF mimic **8** inhibited DNA cleavage by *Tsp*509 (lanes 6 and 7); DNA was degraded by the enzyme in absence of peptide **8** (lanes 8 and 9). An interaction between the enzyme and peptide **8** is likely to prevent binding of peptide **8** at dsDNA and cleavage of DNA by the restriction enzyme.Fig. 4Agarose gel electrophoresis (1%). *Leftlane 1* 100 bp DNA marker, *lanes 2 and 3* 200 bp DNA H′-middle and H′-edge, *lanes 4 and 5* peptide **8** (Pro) + 200 bp DNA H′-middle and H′-edge; *lanes 6 and 7* peptide **8** (Pro) + 200 bp DNA H′-middle and H′-edge + *Tsp*509 restriction enzyme, *lanes 8 and 9* 200 bp DNA H′-middle and H′-edge + *Tsp*509 restriction enzyme, *lanes 10 and 11* 200 bp DNA H′-edge and H′-middle. *Right* Enlargement of *lanes 4 and 5* migration difference of mimic **8** binding in the middle or terminal position of 200 bp DNA

IHF analogs with aromatic intercalator side chains {#Sec13}
--------------------------------------------------

Phenylalanine (**14a**) and 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (**14b**) IHF analogs were prepared based on the hypothesis that a larger aromatic side chain might increase the interaction with the dsDNA base pair stack at the intercalator site. Gel electrophoresis of these peptides with the 200 bp DNA containing the H′-edge and H′-middle recognition sequence were performed (Fig. [5](#Fig5){ref-type="fig"}).Fig. 5Agarose gel electrophoresis (1%). *Leftlane 1* 100 bp DNA marker, *lane 2* 200 bp DNA, *lanes 3 and 4* peptide **14a** (Phe) + 200 bp DNA H′-middle and H′-edge. *Rightlane 1* 100 bp DNA marker, *lane 2* 200 bp DNA, *lanes 3 and 4* peptide **14b** (Thi) + 200 bp DNA H′-middle and H′-edge

Both peptides **14a** and **14b** provided DNA retardation indicating binding of the IHF analog. Nevertheless, a significant smearing of the bands revealed a loss of specificity in peptide binding. It was concluded that large intercalating side chains are in conflict with the recognition motif of the IHF α-arm in the minor groove.

IHF-analogs with proline derived intercalator side chains {#Sec14}
---------------------------------------------------------

Since there seems to be a size restriction of the intercalating unit, the contribution of the proline residues in the IHF arms was further investigated with respect to the proline ring conformation. Since the co-crystal structure of IHF with dsDNA indicates an exo-Pro65 conformation in the α-arm and an endo-Pro64 in the β-arm (Fig. [6](#Fig6){ref-type="fig"}), the conformation might be of significant importance for recognition. Electronegative substituents of the proline ring result in a preferred endo or exo-Pro conformation based on stereoelectronic effects (Barth et al. [@CR2]; Hodges and Raines [@CR15]; Sonntag et al. [@CR30]; Erdmann et al. [@CR8]; Lesarri et al. [@CR19]; Horng and Raines [@CR16]; Naduthambi and Zondlo [@CR23]). The influence of the 4-fluoroproline configuration can be envisaged by (4R)-fluoroproline diastereomer stabilizing the triple helix of collagen, whereas the (4S)-diastereomer has an destabilizing effect (Barth et al. [@CR2]; Hodges and Raines [@CR15]; Renner et al. [@CR25]). The IHF-mimics were synthesized containing (4S)-FPro (**14c**) stabilizing the endo-conformation and (4R)-FPro (**14d**) with preference for the exo-conformer. In a gel electrophoresis study with the H′-edge and H′-middle 200 bp DNA sequences (Fig. [7](#Fig7){ref-type="fig"}) for both peptides **14c** and **14d** retardation of the bands was recognized indicating the formation of recognition complexes between DNA and the IHF analogs. In comparison to the exo-Pro mimic, the endo-Pro intercalating peptide **14c** provided a stronger band-shift but also lower specificity indicated by broader bands (lanes 8 and 9) whereas the bands of the exo-Pro peptide **14d** in complex with dsDNA are sharp (lanes 10 and 11). The higher specificity of **14d** is in accordance to the exo-Pro conformation of the α-arm in the IHF/DNA co-crystal structure. In addition, there was no difference in binding of peptide **14c** to the H′-edge or H′-middle position of the 200 bp DNA, whereas recognition of **14d** provided slightly higher retardation for complexation at the H′-middle binding site due to a higher degree of curvature. From this experiment it can be concluded that recognition of the α-arm of IHF is strongly relying on the exo-Pro65 conformation.Fig. 6Intercalating proline residues enlarged from the α and β-arm of the IHF DNA co-crystal structure (Rice et al. [@CR27]) together with the respective fluoroproline derivatives as conformational mimicsFig. 7Agarose gel electrophoresis (2%): *lane 1* 50 bp DNA marker, *lanes 2 and 3* 200 bp DNA H'-edge and H'-middle;*lanes 4 and 5* peptide 8 (Pro) + 200 bp DNA H'-edge and H'-middle (1:200);*lanes 6 and 7* peptide 14e (Dh-Pro) + 200 bp DNA H'-edge and H'-middle (1:200);*lanes 8 and 9* peptide 14c ((4S)-FPro) + 200 bp DNA H'-edge and H'-middle (1:200);*lanes 10 and 11* peptide 14d ((4R)-FPro) + 200 bp DNA H'-edge and H'-middle (1:200);*lanes 12 and 13* peptide 14f αMe-Pro) + 200 bp DNA H'-edge and H'-middle (1:200)

3,4-Dehydroproline provides a nearly planar five-membered ring (Benedetti et al. [@CR3]; Fisher et al. [@CR11]). In gel electrophoresis considering the interaction of the Dh-Pro modified IHF analog **14e** with 200 bp DNA (Fig. [7](#Fig7){ref-type="fig"}, lanes 6 and 7) non specific binding was observed comparable to the endo-Pro peptide **14c** interaction. The restriction to planar ring conformation seems to disturb proper fitting inhibiting specific recognition. Nevertheless, the interaction of peptide **14e** with dsDNA is indicated by significantly shifted bands in the gel electrophoresis.

Finally, exchange of the intercalating proline in the α-arm of IHF against α-methylproline was performed synthesizing IHF analog **14f**. α-Methylproline has a β-turn inducing effect (Welsh et al. [@CR33]; Hinds et al. [@CR14]). Therefore, it was expected that an additional methyl group at the peptide backbone of the α-arm of the IHF analogs strongly affects the cyclopeptide conformation. Indeed, in gel electrophoresis experiment of 200 bp DNA with IHF analog **14f** no indication of recognition was found (Fig. [7](#Fig7){ref-type="fig"}, lanes 12 and 13). The additional α-methyl group at the intercalating proline significantly disturbs the β-sheet conformation of the minor groove binding loop thereby completely interrupting DNA binding.

H′-edge and H′-middle; lanes 4 and 5: peptide **8** (Pro) + 200 bp DNA H′-edge and H′-middle (1:200); lanes 6 and 7: peptide **14e** (Dh-Pro) + 200 bp DNA H′-edge and H′-middle (1:200); lanes 8 and 9: peptide **14c** ((4S)-FPro) + 200 bp DNA H′-edge and H′-middle (1:200); lanes 10 and 11: peptide **14d** ((4R)-FPro) + 200 bp DNA H′-edge and H′-middle (1:200); lanes 12 and 13: peptide **14f** αMe-Pro) + 200 bp DNA H′-edge and H′-middle (1:200).

Fluorescence resonance energy transfer (FRET) {#Sec15}
---------------------------------------------

Integration host factor-induced bending of dsDNA was also analyzed by FRET using a 55 bp dsDNA (5′ 6-FAM CCCAC GGCAT TATAA AAAAG CATTG CTTAT CAATT TGTTG CAACG AACAG GTCGG-3′ + 5′-TAMRA GGGTG CCGTA ATATT TTTTC GTAAC GAATA GTTAA ACAAC GTTGC TTGTC CAGCC-3′) that contains the λ phage H′-binding site and labeling of both 5′-terminal ends with fluorescein (FAM) and tetramethylrhodamine (TAMRA), respectively (Lorenz et al. [@CR21]). Fluorescence quenching of about 50% was observed at 520 nm adding the DNA binding IHF domain which can be correlated to a fluorophore distance of 51 Å in accordance to the crystal structure (Rice et al. [@CR27]; Lorenz et al. [@CR21]). The 55 bp fluorescence labeled DNA double strand used for the FRET with IHF/DNA experiments was also applied to investigate the bending potential of the IHF analogs **8** and **14c--e** with modified Pro65 residue (Fig. [8](#Fig8){ref-type="fig"}). The IHF analog DNA complexes were analyzed in a 200:1 ratio using a Tris HCl buffer (10 m[m]{.smallcaps} Tris--HCl, 10 m[m]{.smallcaps} EDTA, 100 m[m]{.smallcaps} NaCl, 1 m[m]{.smallcaps} dithiothreitol and pH 7.5, incubated for 3 h at r.t. and excited at 496 nm).Fig. 8Fluorescence emission spectra for 55 bp DNA and complexes with the IHF-mimics **8** and **14c**--**e**. Donor fluorescence spectra of the IHF-mimics **8** and **14c**--**e** were normalized to the fluorescence of the free 55 bp DNA

The proline IHF mimic **8** provided a fluorescence quenching effect of 25% in agreement with specific DNA binding not bending dsDNA to the same extent as IHF. The quenching effect induced by the (4R)-fluoroproline derivative **14d** turned out to be even lower. This difference in bending was already indicated by gel electrophoresis (**8** in Fig. [4](#Fig4){ref-type="fig"} vs. **14d** in Fig. [7](#Fig7){ref-type="fig"}). Nevertheless, the exo-conformation of Pro65 in the α-arm of IHF resembled and well stabilized by (4R)-fluorine substitution seems to be decisive for recognition and binding specificity but does not lead to increased dsDNA bending. In contrast, the (4S)-fluoroproline and 3,4-dehydroproline derivatives **14c** and **14e** provided high fluorescence quenching of 42 and 50%, respectively. Both derivatives were non-specific-binders according to gel electrophoresis. Charge interaction seems to gain more importance and non-specific binding implies that even more than one equivalent of peptide might be involved in dsDNA interaction.

Conclusion {#Sec16}
==========

The IHF protein domain bending dsDNA more than 160° was imitated by a peptide composed of a lysine dendrimer linked to a cyclopeptide. The dendrimer provides the positive charges for non-specific binding and the cyclopeptide with a sequence related to the IHF α-arm specifically binding in the minor groove. The Pro65 amino acid within the α-arm is especially interesting since the ring is intercalated into the DNA base pair plane at the kinking position. A comparable study of IHF analogs was performed varying the proline derivatives. Larger aromatic residues like Phe and tetrahydroisoquinoline carboxylic acid were not tolerated as Pro substitutes. Introduction of the turn inducing α-methylproline indicated the importance of the β-sheet like conformation of the α-arm resembling cyclopeptide since binding was suppressed in the respective analog. The influence of the proline ring conformation was investigated by introduction of the endo-conformation stabilizing (4S)-fluoroproline and the exo-conformation preferring (4R)-fluoroproline. Specific binding was indicated only for the (4R)-FPro derivative imitating the exo-conformation that was found in the IHF/DNA co-crystal structure for Pro65 in the α-arm. The (4S)-FPro turned out to be a DNA binder with lower specificity; comparable binding was obtained for 3,4-dehydroproline with a planar ring conformation. The preparation and DNA interaction of IHF mimics should be a useful tool for further understanding of protein/DNA recognition on the molecular level.
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